Clinical patterns among invasive pulmonary aspergillosis patients with and without recent intensive immunosuppressive therapy

Journal of the Formosan Medical Association

Volumn 100, Issue 11, 2001, Pages 762-766

  Chang, Gee Chang ^a   Chang, Kai Ming ^a   Wu, Chieh Liang ^a   Chiang, Chi Der ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Immunosuppresive therapy; Invasive pulmonary aspergillosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DRUG MEGADOSE; FEMALE; FOLLOW UP; FUNGUS CULTURE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; MALE; MEDICAL RECORD; MORTALITY; NONHUMAN; RECURRENT INFECTION; SYMPTOM; THORAX RADIOGRAPHY;

ADULT; ASPERGILLOSIS; BIOPSY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, FUNGAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035695834     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aspergillosis of the lung-an eighteen-year experience
2. The pulmonary aspergillosis: Three distinct entities or spectrum of disease
3. Aspergillus fumigatus and lung disease
4. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease
5. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases
6. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy
7. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes
8. Damage to hyphal forms of fungi by human leukocytes in vitro: A possible host defense mechanism in aspergillosis and mucormycosis
9. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon
10. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae
11. Aspergillosis; the spectrum of the disease in 98 patients
12. Fungal infections in patients with acute leukemia
13. Therapeutic outcome in invasive aspergillosis
14. Incidence, severity, and prevention of infections in chronic granulomatous disease
15. Disseminated aspergillosis in an apparently immunocompetent host
16. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts
17. Chronic invasive aspergillosis in apparently immunocompetent hosts
18. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
19. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis
20. Pulmonary nodules and the CT halo sign
21. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
22. Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection
23. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients